FDA Drug Approvals — 2019 Midyear Review

Mary L Windle, PharmD

August 09, 2019

Other Agents

Cimzia (certolizumab pegol) gained approval for active nonradiographic axial spondyloarthritis with objective signs of inflammation.

References

1 2 3 4 5 6 7 8 9 10 11

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Mary L Windle. FDA Drug Approvals — 2019 Midyear Review - Medscape - Aug 09, 2019.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

FDA Drug Approvals — 2019 Midyear Review

Other Agents

Tables

References

Authors and Disclosures

Authors and Disclosures

Author(s)

Mary L Windle, PharmD

Comments

Email This

Feedback